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The antibody responses of CBA and C57 mice to a series of multichain synthetic 
polypeptide antigens  are quantitative traits which  are under a  dominant, determi- 
nant-specitic  type of genetic control (1, 2). These antigens (2) are composed of a poly- 
lysine backbone with side chains of poly-nL-alanine terminating in short, random se- 
quences of either tyrosine and glutamic acid, [(T, G)-A--L], or histidine and glutamic 
acid, [(I-I, G)-A--L], or phenylalanine and glutamic acid, [(P, G)-A--L]. The multipoly- 
alanyl-polylysine (A--L) part of these antigens is not antigenic by itself, and the anti- 
body response to (T, G)-A--L is specific for the tyrosine, glutamic acid, and alanine 
at the end of each side chain (1). CBA and  C3H mice respond well to (H, G)-A-L 
and  poorly to  (T,  G)-A-L, while  C57  mice  respond  poorly to (H, G)-A--L  and 
well to (T, G)-A--L  (1, 2). The quantitative difference between CBA and C57 mice 
with respect to anti-(T,  G)-A--L response is approximately tenfold (1). While  these 
differences  are clearly quantitative, high responder mice will be termed responders, 
and low responder mice will be termed nonresponders for the sake of simplicity. 
The mechanism  of the genetic control responsible for these  differences in 
immune response is unknown.  It has been shown that the ability to respond 
to (T, G)-A--L is not correlated with the immunoglobulin class of the result- 
ant anti-(T,G)-A--L or with the possession by the responding animal of the 
immunoglobulin  allotype of the high  responder parental  strain  (3).  No  evi- 
dence is yet available with regard to possible genetic control of the structure 
of the anti-(T,G)-A--L combining site itself. In the present study,  attempts 
were made to transfer the ability to respond to (T, G)-A--L by the transfer of 
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spleen cells from responder to nonresponder animals in order to find out whether 
this genetic control is directly related to  the process of antibody formation, 
or is an indirect result of genetic effects on processes completely unrelated to 
antibody formation.  Examples  of effects  on  processes unrelated  to  antibody 
formation might include the production (by the nonresponder strain) of sub- 
stances which bind the antigen,  or enzymes which destroy it. The results in- 
dicate that  this genetic control is directly related to the process of antibody 
formation and can be localized to spleen cells, since it is possible to transfer the 
ability to respond well to (T,G)-A--L from high responder (C3H  ×  C57B1/6) 
F1  mice into irradiated, low responder C3H  recipients by transferring disso- 
ciated F1 spleen cells. In the course of these studies, a  search for a  more con- 
venient cell transfer system utilizing congenic strains of mice led to  the dis- 
covery that the major genetic factor controlling the ability to respond well to 
(T,G)-A--L and  (H,G)-A--L is genetically linked to the Histocompatibility-2 
(H-2)  locus and can thus be localized to the IXth mouse linkage group. 
Materials and Methods 
C3H  and  C57B1/6 mice were  obtained from the Jackson Memorial Laboratories, Bar 
Harbor, Maine. The (C3H X  C57B1/6) F1 mice were bred and maintained at the U.S. Naval 
Radiological Defense Laboratory, San Francisco. 
CBA, C57, (CBA X  C57) FL, FI X  CBA, and F1 X  C57 mice were bred from strains orig- 
inally obtained from the National Institute for Medical Research,  Mill Hill, London, and 
were maintained at Stanford. Mice of the following strains were purchased from the Jackson 
Memorial Laboratories: A, A.BY, C57B1/10, B10.BR,  C3H/Hc, and C3H.SW. 
The antigens used,  and the methods of immunization and bleeding have been  described 
previously (1, 2). In general,  mice were given a primary stimulus with 10 #g  (T,G)-A-L 
509 (1) in complete Freund's adjuvant in the hind footpads or subcutaneously  in the abdomi- 
nal wall. The adjuvant contained 2 mg/mi killed Mycobactericum tuberculosis H37/ra, kindly 
supplied by Dr.  Sidney Raffel. 3 wk after the primary stimulus,  the mice received  10 #g 
(T, G)-A--L 509 in aqueous solution as a secondary stimulus.  The animals were bled 10 days 
after the secondary stimulus. Any deviations from this procedure will be indicated. 
The antibody assay used was a modification of that previously described  (1), based on the 
method described by Herzenberg  et al. (4). 50/zl of antigen solution, containing 0.0025/zg  of 
(T,G)-A--L 509 1~5I and 1% bovine serum albumin in phosphate buffered saline (0.15 N, pH 
7.0) was mixed with 25 /zl of the appropriate dilution of mouse  antiserum  (~0  through 
~0o) and incubated 30 rain at 37°C and 2 hr at 4°C. Mter incubation,  25 /~1 of the appro- 
priate dilution of polyvalent rabbit anti-mouse T-globulin antiserum (undiluted, ~'~, ~, ~'~0) 
was added, followed by a second period of incubation.  The mixture was then centrifuged  at 
10,000 g at 4°C in a Servall GSA rotor. At this speed, the very small amounts of soluble com- 
plexes composed of (T,G)-A--L, mouse anti-(T,G)-A--L, and rabbit anti-mouse T-globulin 
are sedimented on the bottom of the centrifuge tube, and one-half  (50/zl) of the supernatant 
can then be removed and counted in a well-type gamma scintillation counter and the results 
expressed as the per cent antigen bound in the complexes. Antibody titers are thus given as 
per cent values. Extensive preliminary testing showed that  (a) the per cent antigen bound 
at all dilutions of normal mouse serum was 0-5%, (b) 86-90% of the counts were precipitable 
by specific antibody, (c) the relative values for per cent antigen bound were very similar to 
those obtained by the method previously used  (1). If anything, differences between  CBA HUGH  O.  McDEVITT  AND  MARVIN  L.  TYAN 
and C57 sera are larger at high dilutions of antisera. Antisera were frequently tested at more 
than one dilution, and the same dilution was tested against more than one dilution of rabbit 
anti-mouse T-globulin to eliminate possible artifacts produced by using too high a  dilution 
of antiserum,  by using too llttte rabbit anti-mouse "),-globulin to precipitate all the mouse 
antibody, or by using such an excess of rabbit antibody that anti-(T,G)-A-L sites on mouse 
antibody were steficaily blocked. 
12-15 wk old thymectomized and nonoperated male and female C3H and (C3H X  C57B1/6) 
F, mice were used as recipients in cell transfer studies. All mice received 840 rad whole body 
X-radiation  (250  kvp,  15 ma; haft-value layer,  1.5  mm Cu;  30 tad/rain).  The mice were 
housed 10 to a cage. Adult male and female C3H and  (C3H X  C57B1/5)  F1 mice were used 
as donors of spleen and lymph node cells. The spleen and lymph nodes were removed asep- 
tically and the cells were gently dissociated in cold TC 199 (Difco Laboratorie% Inc., Detroit, 
Mich.). Aliquots of each cell suspension,  containing between 100 X  106 and 150 X  106 viable 
nucleated cells, were injected intrapefitoneally into the hosts shortly after they were irradi- 
ated. 
H-2  typing was done by standard  methods of hemagglufination (5),  using anti-H-2  b and 
anti-H-g k antisera kindly supplied by Dr. L. A. Herzenberg. The results were scored without 
knowledge of the source of red cells, and with the presence in random order of known posi- 
tive and negative red cell suspensions.  Great difficulty was encountered in correctly detecting 
H-2  b- on C57 and  (CBA X  C57)  Fx red cells. For this reason, three separate determinations 
were done on all (CBA X  C57)  FIX  CBA mice tested, and the controls used were C3H 
(tt-2, k)  and  C3H.SW  (//-2  b)  red  cell suspensions,  which  gave accurate  and  reproducible 
results. 
RESULTS 
Adoptive Transfer of a Secondary Antibody Response to (T,G)-A--L.--Table 
I  presents  the results  obtained  by transferring spleen  cells  from animals  al- 
ready  immunized  to  (T,G)-A--L  into  irradiated  C3H  recipients.  Groups  1 
and 2 are the controls  and show the response of intact (C3H  X  C57B1/6)  Fx 
mice  and  C3H  mice to  a  standard  imnaunization with  (T,G)-A--L.  The F1 
mice have a per cent antigen  bound value of 53 % and C3H mice have a per 
cent  antigen  bound value  of 3 %. Titering these  antisera  at lower  dilutions 
does not appreciably  change  the results.  Groups 3, 4,  and 5 show the results 
of  transferring  normal  or immunized  C3H  spleen  cells  into irradiated  C3H 
recipients followed by a second injection of antigen  either at the time of trans- 
fer (group 4) or 10 days after transfer (group 5). The results in all three cases 
indicate that these animals behave in the same way as the low responder in- 
tact C3H mice. Groups 6, 7, and 8 show the results of transferring normal or 
immunized  (C3H  ×  C57B1/6)  F1 spleen  ceils into irradiated  C3H recipients 
followed by a second injection  of antigen  either at the time of transfer (group 
7) or 10 days after transfer (group 8). Normal F1 spleen cells transferred into 
irradiated  C3H recipients  followed by a standard  injection  of (T,G)-A--L in 
aqueous solution failed to give any response. Immunized  F1 spleen cells trans- 
ferred into irradiated C3H recipients followed by a secondary  stimulus  either 
at the time of transfer or 10 days after transfer gave an antibody response 10 
days later which is almost as high as that given by the intact (C3H X  C57B1/6) 4  GENETIC  CONTROL  OF  ANTIBODY  RESPONSE 
Recipients* 
1. (C3H X 
C57B1/6) 
F~ (10) 
TABLE  I 
Adoptive Transfer of a Secondary Response to (T, G)-A--L with 
Recipient 
irradiation 
prior to 
transfer 
tad 
None 
2. C3H(10)  None 
3. C3H(8)  840 
4. C3H(9)  840 
S. C3H(10)  840 
6. C3H(10)  840 
7. C3H(10)  840 
(C3H X  C57Bl/6) Fi Spleen 
Cell donor~ 
None  3 wk 
None  3 wk 
Untreated C3H 
C3H immu- 
nized § 3 wk 
prior to 
transfer 
Same as 4 
(C3H X C57BI/6) 
F1 untreated 
(C3H X  C57B1/6) 
Fi immunized 
3 wk prior to 
transfer 
8. C3H(10)  840  Same as 7 
Time ol 
secondary 
stimulus§ 
Time of 
transfer 
Time of 
transfer 
10 days 
after 
transfer 
Time of 
transfer 
Time of 
transfer 
10 days 
after 
transfer 
:ells 
Average tiler 
prior to 
secondary 
stimulusll 
--¶ 
2% (1/50) 
2%(1/10) 
s% (1/5o) 
one mouse 
had 
titer 
=  32% 
Average titer and 
range 10 days after 
secondary stlmulusI[ 
% 
58 (18-68) (1/500) 
71 (46-81) (1/lOO) 
70 (44-81) (1/10) 
I (0-2) (1/5oo) 
1 (0-3)  0/100) 
I (0-2) (1/10) 
4 (0-9) (1/10) 
8(0-15)  (I/lO) 
4(0-20)  (1/50) 
0  (1/50) 
59  (1  =  2%; 9  = 
22-81%) 
(1/50) 
5s (32-79)  (1/50) 
* Number of recipients in parentheses; approximately equal numbers of males and females. 
Ag irradiated hosts received 3  X  108 normal C3H hone marrow cells i.v.,  as well as 
125-150 X  10  s spleen cells i.p., from the indicated cell donors. 
§ Primary stimulus in either intact (groups 1 and 2) animals or in the spleen cell donors 
(4,  5,  7, 8) was 10/~g (T, G)-A-L 509 in complete Freund's adjuvant. Secondary stimulus 
in all groups was 10 pg (T, G)-A-L in aqueous solution. 
[[ Fractions in parentheses indicate the dilutions at which the sera were titered.  (Please 
see Materials and Methods.) 
¶ --, indicates that sera were not obtained prior to the secondary stimulus. HUGH  O. McDEVITT AND  MARVIN  L. TYAN 
F1 mice in group 1. That this is definitely a secondary response is shown by 
group 8 in which the titer, 10 days after transfer and just prior to boosting, is 
5 %, rising  to 56% 10 days after the booster injection.  Groups 3 and 6 were 
later  given  a  standard  primary  and  secondary  stimulus  with  (T,G)-A--L. 
Both  groups  failed  to  respond,  although  on  the  basis  of  the  above  results, 
group  6  was  expected  to  respond.  No  definite  explanation  can  be  given  for 
this  anomalous result.  All the animals in group 6  accepted Fx skin grafts and 
their  sera  contained  immunoglobnl~n  of donor  allotype.  It is possible  that  a 
TABLE II 
Adoptive Transfer of a Primary Response to (T, G)-A-L to Lethally Irradiated 
CSH Hosts with (CSH X  C57Bl/6) Fx Spleen Cells* 
Recipients~ 
Thymectomized C3H  9  (7) 
Normal C3H  9  (7) 
Normal C3H o  ~ (9) 
Thymectomized C3H  9  (5) 
Normal (C3H X  C57B1/6) Fx 
e  (5) 
Normal (C3H X  C57B1/6) F1 
~(4) 
Primary 
stimulus,§ 
days after 
radiation 
Titer I0 days after secondary stimulusH 
52,  19,  10,  58,  0,  0,  65  (1/50) 
13,  60,  41,  51,  50,  8,  54  (1/50) 
39,  8,  49,  45,  0,  63,  52,  50,  73  (1/50) 
46,  17,  54,  72,  26  (1/50) 
76,  59,  58,  50,  47  (1/50) 
0 
0 
21 
21 
21 
69,  76,  71,  65  (1/50) 
Summary: FI --~ C$H --  38%  (19/28) 
FI ~  Fx =  63%  (9/9) 
C3H --* C3H  ffi 8%  (see Tsble I) 
* Spleen cell dose in all these transfers was 100-150  X  10  e (C3H X  C57B1/6) Fx spleen 
cells per recipient. 
Number of recipients in parentheses. 
§ 1  ° stimulus was 10 Dg (T, G)-A-L 509 in complete Freund's adjuvant. 2 ° stimulus was 
10 Dg (T, G)-A--L 509 in aqueous solution given 3 wk later. 
[[ Titer is average per cent antigen bound.  Figures in parentheses indicate dilution  at 
which antisera were fitered. 
first injection  of (T,G)-A--L in  aqueous  solution  induced  partial  or complete 
tolerance in the F1 spleen cells. 
These results  show  that  it is possible  to  transfer  a  secondary  response  to 
(T,G)-A--L  by  transferring  previously  immunized  spleen  cells  from  an  F1 
responder strain into an irradiated,  nonresponder  parental strain. 
Adoptive  Transfer  of  a  Primary  Antibody  Response  to  (T,G)-A--L.--The 
results of transferring  normal Fx spleen cells into irradiated  Fx or  C3H recipi- 
ents, followed by ~mmunlzation with  (T, G)-A--L in Freund's  adjuvant  and a 
secondary  stimulus  of  (T,G)-A--L  in  aqueous  solution,  are  shown  in  Table 
II. This table presents the results of several different experiments which can- GENETIC CONTROL  OF ANTIBODY  RESPONSE 
not easily be grouped together because the recipients in some cases were thy- 
mectomized. The results show that in  19 out of 28 cases in which normal F1 
spleen ceils were  transferred into irradiated  C3H recipients  (thymectomized 
[7/12] or nonthymectomized [12/16]) followed by immunization either imme- 
diately after cell transfer or 3  wk  after cell transfer,  the recipients gave an 
antibody response with an average per cent antigen bound value for the entire 
group of 38 %. The average per cent antigen-bound value for the 19 animals 
in which transfer was successful is 53 %. Both these values are considerably in 
excess  of  the  immune  response  of intact  C3H  mice  to  immunization  with 
(T, G)-A--L (see Table I). When FI spleen cells were transferred into irradiated 
FI recipients, and the recipients immunized either at the time of transfer or 3 
wk after transfer, all of the animals responded with an antibody response that 
gave an average per cent antigen-bound value of 63 %. This is as high as the 
response of intact  F1  mice to this  type of immunization.  The transfer of F1 
spleen ceils into C3H mice transfers the ability to respond almost as well as 
intact FI mice (antibody titers in the two groups are completely overlapping) 
and much better than intact C3H mice. It should be noted that the FI spleen 
cells remain capable of responding up to 3  wk  after transfer,  and that  they 
respond  equally  well  in  thymectomized  or  nonthymectomlzed  C3H  hosts. 
The fact that F1 cells appear not to respond quite as well or as reproducibly 
in C3H hosts as they do in syngeneic F1 hosts appears reasonable since the F1 
cells may not thrive as well in a parental strain as in a syngeneic host (6). 
From these results, it seems clear that there is no property of the C3H host 
which renders it incapable of supporting a response to (T,G)-A--L, but rather 
that  the C3H spleen cells are incapable of responding to  (T,G)-A--L, while 
F1 spleen cells are capable of responding to this antigen in either a C3H or an 
Fx host. 
Immune Response  of Congenic Strains  of Mice to  (T,G)-A--L  and  (H,G)- 
A--L.--Nttmerous attempts to transfer spleen cells from C57 donors to CBA 
or C3H recipients led to failures attributable to radiation deaths and to deaths 
due to graft vs. host disease. Because of these difficulties, a  systematic study 
of several congenic strains of mice available from the Jackson Memorial Lab- 
oratories was  undertaken  in  an  attempt  to find strains  of mice which were 
congenic with either C57  or C3H, but which contained the major histocom- 
patibility antigens  (//-2)  of either the C3H  or C57 strains,  respectively. By 
this means, it was hoped to develop a more convenient cell transfer system in 
which graft vs. host disease would be minimized. The results of these studies 
are  shown in Table HI.  C3H mice, which  are tt-2  k, respond to  (T,G)-A--L 
and (H,G)-A--L  as  do CBA  mice  (also //-2k),  i.e., they respond  poorly  to 
(T,G)-A--L. C3H.SW mice, which are congenic with C3H/DiSn mice (similar 
to C3H mice) and which are//-2  b, do not respond to these antigens in the same 
manner as C3H mice. C3H.SW mice respond well to (T,G)-A--L and poorly HUGH O.  McDEVITT AND MARVIN L.  TYAN 
to (H,G)-A--L, as do C57 mice, which are also 11-2  b. Similar results were ob- 
tained with B10.BR mice, which are congenic with C57BI/10 ScSn mice, and 
A.BY mice, which are congenic with A/WySn mice (similar to A/J mice). An 
examination of Table HI suggests that the ability to respond well or poorly 
to (T, G)-A--L or (H,G)-A--L can be bred in  or out  of a  strain  by selecting 
for H-2  b in the case of (T, G)-A--L and for 11-2  a or H-2  k in the case of (H, G)- 
A--L, 
Linkage Studies.raThe hypothesis that the ability to respond well to (T, G)- 
A--L and (H,G,)-A--L is genetically linked to the tt-2 locus was  tested by 
correlating 1t-2 type with antibody response in a  segregating population.  In 
TABLE III 
Response of Congenic Strains of Mice to Syntketic Polypeptide Antigens 
Strain* 
A/J 
A.BY 
C57 
C57B1/10 
B10.Br 
C3H 
C3H.SW 
H-2 type 
a 
b 
(T, G)-A-L 
% 
10  (6-15) 
78  (62-87) 
69  (51-77) 
32  (7-62) 
7  (2-14) 
10  (0-31) 
79  (52-91) 
Response 
(H, G)-A-Lt 
% 
66  (29-81) 
0 
28  (7-55) 
44  (17-78) 
0 
* Five males and five females of each strain. 
Responses to (H, G)-A-L were titered with (T, G)-A-L 509-mI, by virtue of the ex- 
tensive cross-reactions  of these antigens, and therefore give lower per cent antigen bound 
values than with the homologous  antigen (2). 
the case of (T,G)-A-L, the population tested was a (CBA X  C57) FI X  CBA 
backcross. In this subline, approximately half of the animals respond well to 
(T,G)-A--L and half of them respond poorly (1). In addition, since the cross 
is that of an H-2s/11-2  k heterozygote by an H-2k/H-2  k homozygote, one-half 
of the offspring would be expected to be H-2b/H-2  k heterozygotes, and one- 
half would be H-gk/H-2  k homozygotes. The results of these tests are shown in 
Table IV.  14 out of the 15 mice which responded to (T,G)-A--L were H-2  b- 
positive, while 22 out of 23 nonresponders were H-gb-negative, i.e., were H-2k/ 
//-2  k homozygotes. This results confirms the initial hypothesis that the ability 
to respond to (T,G)-A--L is a  genetic trait which is linked to the H-2 locus. 
The finding of two recombinant animals  in  38  animals  tested could be due 
either to failure to immunize these animals properly, or to mistakes in tt-2 GENETIC  CONTROL  OF  ANTIBODY  RESPONSE 
typing. It is not possible to reimmunize the animals and be certain of the re- 
suits.  The 11-2  typing was  repeated  three  times  in  all mice,  with  the  same 
results each time. Breeding tests of the recombinant animals are currently in 
progress,  and  if their  offspring conform to their  designated genotype, it will 
TABLE IV 
Linkage of (T, G)-A--L Response to H-2  b* 
(CBA X  C57)Ft X  CBA 
Responders 
8  (21-75%) 
7  (22-74%) 
15 
Nonresponders 
10  (2-12%) 
13  (0%) 
23 
Positive 
8 
6 
14 
H-2  b 
0 
1 
1 
Negative 
0 
1 
1 
10 
12 
22 
Total recombinants =  2/38. 
* The results given are those of two separate experiments. 
TABLE V 
Linkage of (H, G)-A--L Response to H-2  ~ 
(CBA X  C57)F1 X  C57 
Responders* 
6  (lO-45%) 
Nonresponders 
14  (0%) 
Positive 
H-2  k 
Negative 
13 
Total recombinants =  1/20. 
* Responses to (H, G)-A--L  were titered with (T, G)-A--L  509-I~L (2) 
indicate that there is a definite low recombination rate between the two traits. 
Such a result would exclude the possibility that 1t-2 antigens affect the immune 
response to (T, G)-A--L and (H, G)-A--L. Results of similar testing for linkage 
of ability to respond to (H, G)-A--L with the 11-2  k marker are shown in Table 
V.  Of six animals that gave a detectable response to (H, G)-A-L, all six were HUGH  O.  McDEVITT  AND  MARVIN  L.  TYAN  9 
H-2k/H-2  b heterozygotes.  Of  14 animals  which  gave  a  low or  undetectable 
response  to  (H,G)-A--L,  13  were  H-2b/H-2  b homozygotes  and  one  was  an 
H-2k/H-2  b heterozygote. This result again confirms the initial hypothesis and 
indicates that ability to respond to (H, G)-A--L is linked to the H-2 locus. 
DISCUSSION 
The finding that the ability to respond to (T, G)-A--L, in either a primary or 
secondary response,  can be transferred  by transferring  responder  spleen cells 
into irradiated nonresponder recipients indicates that the major genetic differ- 
ence between responder and nonresponder  strains of mice is expressed in one 
or more types of cells in a  spleen cell population,  and in all likelihood is di- 
rectly related to the process of antibody formation.  Nothing can be said con- 
cerning  the type of cell responsible, since it is probable that the heterogenous 
spleen cell population  used contained  large lymphocytes,  small lymphocytes, 
plasma  cells,  macrophages,  and  quite  possibly primitive  stem  cells.  Experi- 
ments utilizing  purified cell populations  to transfer  the antibody response  to 
synthetic polypeptide antigens are in progress. Initial  experiments will utilize 
purified macrophages and purified peripheral blood lymphocytes. 
The demonstration  that  the major genetic factor controlling  ability to re- 
spond to synthetic polypeptide antigens is linked to the H-2 locus and can be 
localized to the IXth mouse linkage  group  (7, 8),  is unexpected.  Since there 
appears to be an approximate 5 % recombination rate between the two genetic 
markers,  it seems unlikely that H-2 antigens themselves are directly involved 
in the genetic control of the ability to respond to synthetic polypeptides. The 
IXth mouse linkage group includes the H-2 locus (7), the gene controlling the 
thymus-leukemia  antigen  (8), and  the gene controlling  Serum Substance  (8). 
It  is possible  that  genes  controlling  other  cell surface  antigens,  perhaps  on 
lymphocytes  or  macrophages,  will  be  detected  and  placed  in  this  linkage 
group.  Such  surface  antigens  might  affect the  cell's  ability  to interact  with 
(T,G)-A--L  and  (H,G)-A--L.  It has  already been pointed  out  (1)  that  it is 
unlikely that  the genetic control  of the  ability  to respond  to  (T, G)-A-L  is 
due to sharing  of antigenic  determinants  between  (T,G)-A-L  and  the  non- 
responder animal's self antigens.  Were this the case, nonresponsiveness would 
be dominant  in  the  F1, since the  F~ would possess all  the nonresponder  self 
antigens  (1).  Further  evidence on this  point  comes from  two sources.  First, 
we have tested two C57/B16 anti-CBA isoantisera,  one C57/B1 anti-C3H and 
one C3H.SW anti-C3H  isoantiserum  all made  against  spleen cells, and  these 
do not bind  (T, G)-A--L.  Second, we have recently found (unpublished data) 
that  C57 fetal liver cells can  transfer  the  ability  to respond  well to  (T,G)- 
A-L into irradiated  CBA recipients.  Were cross-reactlon with CBA self anti- 
gens a factor in the poor response of CBA's to (T, G)-A--L, such a result would 
not be possible, since C57 fetal liver cells would be tolerant of CBA antigens. 10  GENETIC  CONTROL  OF  ANTIBODY  RESPONSE 
This result  also rules out the unlikely possibility that  the genetic control/s 
due to "cross-tolerance," but responsiveness is dominant in the F1 because the 
responsible CBA self antigen is recessive in the 171. 
It is also possible that the observed genetic effects are not mediated by cell 
surface  antigens,  but  by  other  mechanisms,  such  as  the  ability  of macro- 
phages to "process" the antigen,  or the presence in the genome of structural 
genes  coding  for  a  particular  antibody  combining  site  complementary  to 
(T,G)-A--L.  The recent report that  susceptibility to  some  types  of murine 
leukemia in some strains of mice is a genetic trait which is also linked to the 
H-2 locus (9) raises the possibility that susceptibility or resistance is mediated 
by ability to synthesize neutralizing antibody, and the further possibility that 
the IXth linkage group includes a  large chromosome region which is in some 
way related to antibody formation. 
SUMMARY 
The transfer of spleen  cells from  (C3H  X  C57B1/6)  F1  mice,  capable  of 
responding to (T, G)-A--L, into irradiated C3H parental recipients, normally 
incapable of responding to (T,G)-A--L, transfers the ability to make either a 
primary or secondary immune response to this synthetic polypeptide antigen. 
This localizes the genetic control of the ability to respond to the spleen cell 
population  and indicates  that  the genetic control is  exerted upon  a  process 
directly related to antibody formation. Studies with congenie strains of mice 
and linkage studies in segregating backcross populations show that the ability 
to respond to (T,G)-A--L and (It,G)-A--L is linked to the H-2 locus and can 
thus be localized to the IXth mouse linkage group. 
Note Added in Proof: Of the three possible recombinant animals noted in Tables IV and 
V, two were infertile. The third animal was not a recombinant, since progeny testing 
and reimmunization showed that this animal was an H-2b/H-2  ~ heterozygote capable 
of responding  well to (T, G)-A-L. 
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